2607.HK Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 май 2024 @ 06:18):

Stats
Объем за сегодня	709 001
Средний объем	2.41M
Рыночная капитализация	57.33B
EPS	HKD0.320 ( 2023-10-27 )
Last Dividend	HKD0.664 ( 2023-07-18 )
Next Dividend	HKD0 ( N/A )
P/E	10.07
ATR14	HKD0.0120 (0.11%)

Объем Корреляция

Длинно: -0.07 (neutral)

Кратко: 0.00 (neutral)

Signal:(58.966) Neutral

Shanghai Pharmaceuticals Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Shanghai Pharmaceuticals Корреляция - Валюта/Сырье

0.50
( neutral )

0.61
( weak )

0.78
( moderate )

-0.02
( neutral )

-0.51
( weak negative )

Shanghai Pharmaceuticals Финансовые показатели

Annual	2023
Выручка:	HKD260.30B
Валовая прибыль:	HKD31.33B (12.04 %)
EPS:	HKD1.020

FY	2023
Выручка:	HKD260.30B
Валовая прибыль:	HKD31.33B (12.04 %)
EPS:	HKD1.020

FY	2022
Выручка:	HKD231.98B
Валовая прибыль:	HKD30.49B (13.14 %)
EPS:	HKD1.610

FY	2021
Выручка:	HKD215.82B
Валовая прибыль:	HKD28.54B (13.23 %)
EPS:	HKD1.790

Financial Reports:

No articles found.

Shanghai Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.984 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.664 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Shanghai Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.96 - good (99.58%) | Divividend Growth Potential Score: 4.20 - Stable (16.02%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.196	2012-06-14
Last Dividend	HKD0.664	2023-07-18
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	13	--
Total Paid Out	HKD5.57	--
Avg. Dividend % Per Year	0.00%	--
Score	2.75	--
Div. Sustainability Score	9.96
Div.Growth Potential Score	4.20
Div. Directional Score	7.08	--

Next Divdend (Est)
(2024-07-11)

HKD0.720 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.75

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2356.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
1330.HK	Ex Dividend Junior	2023-06-28	Annually	0.00%
0386.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
6600.HK	Ex Dividend Knight	2023-06-02	Annually	0.00%
1888.HK	Ex Dividend Knight	2023-12-12	Semi-Annually	0.00%
0914.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
0046.HK	Ex Dividend Knight	2023-08-31	Semi-Annually	0.00%
2858.HK	No Dividend Player	2023-05-15	Insufficient data to determine frequency	0.00%
1459.HK	Ex Dividend Junior	2023-05-25	Annually	0.00%
0538.HK	Ex Dividend Junior	2023-06-12	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0144	1.500	9.71	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0174	1.200	9.42	10.00	[0 - 0.3]
returnOnEquityTTM	0.0553	1.500	-0.497	-0.745	[0.1 - 1]
payoutRatioTTM	1.029	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.336	0.800	8.32	6.65	[1 - 3]
quickRatioTTM	1.058	0.800	8.48	6.78	[0.8 - 2.5]
cashRatioTTM	0.240	1.500	9.78	10.00	[0.2 - 2]
debtRatioTTM	0.226	-1.500	6.23	-9.35	[0 - 0.6]
interestCoverageTTM	4.07	1.000	9.60	9.60	[3 - 30]
operatingCashFlowPerShareTTM	2.14	2.00	9.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.281	2.00	9.36	10.00	[0 - 20]
debtEquityRatioTTM	0.701	-1.500	7.20	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.116	1.000	-1.395	-1.395	[0.2 - 0.8]
operatingProfitMarginTTM	0.0287	1.000	-1.425	-1.425	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.160	1.000	-0.223	-0.223	[0.2 - 2]
assetTurnoverTTM	1.215	0.800	5.23	4.19	[0.5 - 2]
Total Score				9.96

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	9.78	1.000	9.11	0	[1 - 100]
returnOnEquityTTM	0.0553	2.50	-0.319	-0.745	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.281	2.00	9.57	10.00	[0 - 30]
dividendYielPercentageTTM	6.57	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.14	2.00	9.29	10.00	[0 - 30]
payoutRatioTTM	1.029	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	0.0431	1.500	-3.05	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0297	1.000	-1.757	0	[0.1 - 0.5]
Total Score				4.20

Shanghai Pharmaceuticals

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.